Alpha DNA Investment Management’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-31,340
Closed -$778K 216
2023
Q2
$778K Buy
+31,340
New +$778K 0.26% 104